Identification of Fredericamycin E from Streptomyces griseus: Insights into Fredericamycin A Biosynthesis Highlighting Carbaspirocycle Formation
Authors:
- 31 January 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 71 (3) , 431-437
Abstract
Fredericamycin (FDM) A (1), a pentadecaketide featuring two sets of peri-hydroxy tricyclic aromatic moieties connected through a unique asymmetric carbaspiro center, exhibits potent cytotoxicity and represents a novel anticancer drug lead. We have localized previously the fdm gene cluster to a 33 kb DNA segment of Streptomyces griseus ATCC49344, the involvement of which in the biosynthesis of 1 was confirmed by gene inactivation, complementation, and heterologous expression experiments. We now report the isolation and characterization of FDM E (5), a heretofore undetected intermediate for 1 biosynthesis from S. griseus, shedding new insight into the mechanism of carbaspirocycle formation. The structure of 5 was elucidated through the combination of spectroscopic methods and isotope-labeling experiments. The core spiro[4.5]decane scaffold of 5 is characterized by a unique cyclohexa-1,2,4-triketone moiety. Transformation of the spiro[4.5]decane 5 into the spiro[4.4]nonane 1 can be rationalized by a biosynthetic benzilic acid-like rearrangement. This unusual rearrangement can be mimicked in vitro by proceeding under aerobic conditions in the absence of enzyme. FDM E displays cytotoxic activity on par with 1 against a selected set of cancer cells, a finding that further supports the unique molecular topology, resulting from the unprecedented carbaspirocycle as exemplified by 1 and 5, as a novel pharmacophore for this family of anticancer agents.Keywords
This publication has 51 references indexed in Scilit:
- A Novel Synthesis of Highly Substituted Perhydropyrrolizines, Perhydroindolizines, and Pyrrolidines: Inhibition of the Peptidyl‐Prolyl cis/trans Isomerase (PPIase) Pin1Helvetica Chimica Acta, 2007
- Fredericamycin B and C from Streptomyces griseus: Structure Elucidation after 23 YearsThe Journal of Antibiotics, 2004
- Inhibition of topoisomerases by fredericamycin ACancer Chemotherapy and Pharmacology, 1989
- On the formation of oxygenated radicals by fredericamycin A and implications to its anticancer activity: an ESR investigationBiochemistry, 1989
- Structure of fredericamycin A, an antitumor antibiotic of a novel skeletal type. Spectroscopic and mass spectral characterization.The Journal of Antibiotics, 1987
- Magnetic resonance studies of fredericamycin A: evidence for oxygen-dependent free-radical formationBiochemistry, 1986
- Biosynthesis of fredericamycin A, a new antitumor antibioticBiochemistry, 1985
- Fredericamycin A, an antitumor antibiotic of a novel skeletal typeJournal of the American Chemical Society, 1982
- Fredericamycin A a new antitumor antibiotic. II. Biological properties.The Journal of Antibiotics, 1981
- Fredericamycin A a new antitumor antibiotic. I. Production, isolation and physicochemical properties.The Journal of Antibiotics, 1981